generics

After Yusimry’s discount, future prices for Adalimumab are unclear

by

Adalimumab, sold under the brand name Humira, has long been one of the best-selling drugs in the world. But its 20-year period without competition has ended, and despite its best efforts to delay its arrival, drugmaker AbbVie now faces increasing competition from biosimilars entering the market. But a biosimilar about to be launched could be … Read more

Patients are less likely to buy generics after receiving bad news about their health

by

Patients who receive bad news about their health may be less inclined to buy generic drugs, according to the results of a Johns Hopkins University study published recently in the Journal of Marketing.1 The effect of bad news could result in 3% higher total drug spending per patient.2 Most specialists agree that generics have the … Read more